Viral Upper Respiratory Infections Flashcards

1
Q

Rhinovirus structure

A

Non-enveloped
+ssRNA genome (7-8kb)
Icosahedral capsid
Small in size (~30 nm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rhinovirus biological characteristics

A

> 100 serotypes

  • ICAM-1 is the primary cellular receptor used to infect respiratory epithelial cells
  • Temperature sensitive: Grows and replicates more efficiently at 88-90 degrees F (the temperature in the nose) than at 98 degrees F (the temperature in the lungs)
  • Acid labile: destroyed by GI tract
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Rhinovirus life cycle

A
  • Enters host cell via ICAM-1
  • Translation of coat proteins and replication of RNA
  • Encodes its own RNA polymerase
  • Assembly and exit by lysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Rhinovirus Pathogenesis, Symptoms, and complications

A

-Pathogenesis and Symptoms
-Infection lasts about two to four days and self-limiting
-Inflammatory responses caused by rhinovirus leads to:
Nasal discharge
Nasal congestion
Sneezing
Sore throat
Edema and erythema of nasal mucosa
Muscle aches, fatigue, headache, loss of appetite
-Complications:
-rare cases: bronchopenumonia in young children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rhinovirus: Diagnosis, Prevention, Vaccine, Treatment

A
  • Diagnosis: Clinical presentation
  • Preventive Measures:
    • Sanitation and hygiene helps prevent spread
    • Mucosal IgA in nasal secretions are protective
    • Type I INF control viral spread but causes pathogenesis
  • Vaccination
    • Immunity is serotype specific but there are currently no vaccines due to >100 serotypes
  • Treatment: Based on symptoms
    • Treatment is primarily symptomatic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Respiratory Syncytial Virus: (Paramyxovirus family) Structure

A
  • Enveloped
  • negative ssRNA genome
  • Helical capsid
  • 100 – 300 nm
  • Two major envelope proteins
  • F = fusion protein
    • Cause respiratory epithelium to fuse
    • Form mononucleated cells
  • G = attachment protein
  • Encodes its own RNA-dependent-RNA Polymerase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Respiratory Syncytial Virus: (Paramyxovirus family): Biological Characteristics

A

-Transmitted by aerosol droplets and direct contact with contaminated surfaces
-Nosocomial spread is common
-Disease can be severe in immunocompromised people
-Target Cells:
-epithelial cells of URT
-Produces mild illness that is self-limiting.
~50% children <8 months, virus spreads into the LRT causing bronchitis, pneumonia and croup

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Respiratory Syncytial Virus: (Paramyxovirus family): Life Cycle

A
  • negative ssRNA replicates cytoplasmically
  • Assembled RNA and protein binds glycoproteins and gets exocytosed
  • Forms syncytium with all the parts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Respiratory Syncytial Virus: (Paramyxovirus family): Pathogenesis, Symptoms, and Complications

A

Pathogenesis and Symptoms:
-Infection is self-limiting and lasts a week to 10 days
-Runny nose, Fever, Rapid breathing, Continuous coughing
-Wheezing and/or a loud whistling sound while exhaling and breathlessness
-Contraction of abdominal muscles while breathing
-Lips turn blue
-Infection induces protective immunity that is not long lasting leading to repeat infections
-premature infants t fully develop
Complications:
-Disease can be severe in immunocompromised people

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Respiratory Syncytial Virus: (Paramyxovirus family): Diagnosis

A
  • Nasal washings, nasal aspirates or swab samples are useful for antigen detection
  • Rapid diagnosis is carried out using DFA, IFA, ELISA.
  • Viral culture carried out in cell lines such as HeLa, Hep-2, Monkey Kidney cells.
  • CPE is seen in 2-5 days
  • Molecular assays such as RT-PCR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Respiratory Syncytial Virus: (Paramyxovirus family): Treatment

A

-Ribavirin has been used. efficacy has been found to be limited
-O2 treatment & hospitalization for infants w/ severe bronchiolitis
Passive Immunotherapy:
-RespiGam: polyclonal antibody used to prevent serious lower respiratory tract infection by RSV.
-Infants and bone marrow recipients.
-Synagis®(palivizumab): 1st monoclonal antibody successfully developed.
-Anti-F reactive antibody.
-Indicated for the prevention of serious lower respiratory tract disease caused by RSV in pediatric patients at high-risk
Safety and efficacy were established in infants with broncho-pulmonary dysplasia (BPD) and infants with a history of prematurity
-No vaccine available

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Adenovirus: Structure

A
  • Non-enveloped
  • ds linear DNA genome, 36 kbps
  • Icosahedral capsid
  • Largest non-enveloped virus (70-90 nm)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Adenovirus: Biological Characteristics:

A
  • At least 51 serotypes are known
  • Replicates in the nucleus
  • Ubiqiutus DNA virus
  • Immunity is serospecific
  • Transmission is by direct contact
  • Target Cells: Infects mucoepithelial cells in respiratory tract, GI-tract, and conjunctiva or cornea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Adenovirus: Life Cycle

A
  • Binds CAR (Coxsackievirus and Adenovirus receptor) and is taken into the cell
  • In the endosome it makes microtubules to reach the nucleus
  • Encodes it own DNA polymerase: copies the DNA in the nucleus
  • Virus persists in lymphoid tissues (tonsils, adenoids, Peyer’s patches) and kidney.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Adenovirus: Pathogenesis and Symptoms

A
  • Causes 5-10% of febrile illness in early childhood
  • Transmission is by direct contact
  • Fecal-oral, contaminated water, objects, Aerosol droplets
  • Clinical manifestation varies with the age and immune status of the host
  • Immunity is serotype specific
  • Pharyngoconjuctival fever in crowded places such as summer camps, swimming pools – Ad3, 7
    • Conjunctivitis
  • Acute respiratory disease in military recruits – Ad4, 7
  • Febrile, undifferentiated upper respiratory tract infection: Infants, young children (5-10% of cases)
    • Febrile pharyngitis
    • Sore throat, acute hemorrhagic cystitis
  • Pharyngoconjunctival fever (Ad3, 5, 7, 21): Children, adults
  • Acute respiratory disease (Ad4 and Ad7): Military recruits
  • Pertussis-like syndrome: infants, young children
  • Pneumonia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Adenovirus: Immunity

A
  • Humoral
    • Neutralizing antibodies protective against same serotype
    • age 10: most have antibodies against endemic serotypes
  • Cell Mediated
    • CD8 CTL responses are critical in controlling infection
    • Severe infections common if cellular immune defects
    • Encodes proteins that play a role in immune evasion
      • (For ex: E3 protein)
    • down regulates MHC class I
    • inhibit TNF mediated lysis
17
Q

Adenovirus: Diagnosis

A
  • Detection of Antigen
  • A rapid diagnosis from nasopharyngeal aspirates and throat washings
  • Virus Isolation from nasopharyngeal aspirates, throat swabs, and feces
  • Retrospective diagnosis may be made by serology. Complement -Fixation Test most widely used.
  • PCR assays
18
Q

Adenovirus: Treatment

A
  • Symptomatic
  • Sanitation and hygiene can limit spread
  • Disease resolves in 7-10 days
  • Live Ad4 and 7 vaccines used in military but discontinued in 1999 after stopped production
  • New live tablet vaccine (99.3% protection again Ad4 & 7) approved in 2011 for use by the US Military during basic training across the various training sites in the US
19
Q

Epstein Barr virus: Structure

A
  • All Herpesviruses have identical morphology
  • Enveloped
  • Large genome (~80-100 genes)
  • Linear dsDNA
  • Icosahedral capsid
20
Q

Epstein Barr Virus: Biological Characteristics

A
  • g - Herpesviruses : EBV, KSHV/HHV-8
  • restricted host-range
  • latent in lymphocytes and/or endothelial cells
  • Ubiquitous
  • Transmission primarily oral route and virus is shed in the saliva
  • Incubation period lasts about 6-8 weeks with symptoms persisting for 2-3 weeks
  • Target Cells: infect epithelial cells and lymphocytes
21
Q

Epstein Barr Virus: Life Cycle

A
  • Encodes its own DNA-Dependent-DNA Polymerase
  • Encodes numerous host protein homologues to evade immune responses
  • Replicates inside the nucleus
  • Mature virus processed thru ER and golgi and released as mature product
22
Q

Epstein Barr Virus

A
  • adolescents are a major risk group with 35-50% of infections leading to infectious mononucleosis (kissing disease; Glandular fever)
  • Transmission primarily oral route and virus is shed in the saliva
  • Incubation period lasts about 6-8 weeks with symptoms persisting for 2-3 weeks
  • Virus infects and replicates in epithelial and B cells
  • Tonsils: red, swollen, and white patches
  • Throat: red and sore
  • Central: malaise, fatigue, headache, loss of appetite
  • Visual: photophobia
  • Lymph node: swelling
  • Spleen enlargement and abdominal pain
  • Complications:
    • Hodgkin’s and Burkitt’s Lympphoma
    • Nasopharyngeal carcinoma
23
Q

Epstein Barr Virus:

A
  • Atypical lymphocyte: downty cell: CD8+ CTL
  • Agglutination test for heterophile antibodies: Positive monospot test
  • EBV antibody ELISA
  • PCR for EBV genes
24
Q

Epstein Barr Virus: Treatment

A

Symptomatic
IM is self limiting and rapidly controlled by the immune response
No licensed vaccine yet